The European Lead Factory (ELF) works on establishing a compound collection of 500,000 compounds based on non-mainstream scaffolds. Academic research groups and small- and medium-sized enterprises (SMEs) within Europe will have access to the compound library.
A number of companies belonging to the European Federation of Pharmaceutical Industries and Associations (EFPIA) will form a library of 300,000 compounds.
Mercachem is responsible for producing 40,000 compounds from 2012 to 2017 as part of WP12. In this context, we have a good track record and play a major role. We develop complex 3D scaffolds in collaboration with our academic partners: Leiden University, Radboud University Nijmegen, and the Netherlands Cancer Institute in Amsterdam.